  *** Rsks[Ab]IP IVKA(Crosstide)[32P-ATP] is increased irt Egf (10 min)
    *** cells: mESCs in BMLS
    *** inhibited by: PD98059 [pretreatment]
    *** source: 11018520-Fig-2a

  *** Rsks[Ab]IP IVKA(Crosstide)[32P-ATP] is increased irt Egf (10 min)
    *** cells: HEK293 in BMLS
    *** inhibited by: PD98059 [pretreatment]
    *** unaffected by: SB203580 [pretreatment]
    *** source: 9687510-Fig-5b
  *** Rsks[Ab]IP IVKA(Rps6)[32P-ATP] is increased irt Egf (times)
    *** cells: SWISS3T3 in BMLS
    *** times: 0 5++ 10++ 60 90 120 240 360 min
    *** source: 12134156-Fig-1b
  *** Rsks[Ab]IP IVKA(Rps6)[32P-ATP] is increased irt Egf (5 min)
    *** cells: SWISS3T3 in BMLS
    *** source: 1848664-Fig-1
  *** Rsks[Ab]IP IVKA(Rps6)[32P-ATP] is increased irt Egf (times)
    *** cells: SWISS3T3 in BMLS
    *** times: 0 5+++ 10++ 15+ 20+ 30+ 45 60 75 90 120 240 min
    *** source: 1848664-Fig-2

=====================
Total Phosphorylation
=====================

  *** Rsks[Ab]IP phos[32Pi] is increased irt Egf (5 min)
    *** cells: SWISS3T3 in BMLS
    *** source: 1848664-Fig-4

============================
Phosphorylation of FSFV site
============================

  *** Rsks[phosAb] phos(FSFV)[phosAb] is increased irt Egf (15 min)
    *** cells: 3Y1 in BMLS
    *** inhibited by: U0126 [pretreatment] no-bkg-control
    *** source: 15024089-Fig-4a
  *** Rsks[phosAb] phos(FSFV)[phosAb] is increased irt Egf (15 min)
    *** cells: 3Y1 in BMLS
    *** unaffected by: H89 [pretreatment] no-bkg-control
    *** unaffected by: Wortmannin [pretreatment] no-bkg-control
    *** source: 15024089-Fig-5b
  *** Rsks[phosAb] phos(FSFV)[phosAb] is increased irt Egf (15 min)
    *** cells: HEK293E in BMLS
    *** inhibited by: U0126 [pretreatment] no-bkg-control
    *** source: 15024089-Fig-4a

